Most Recent

image: Spinoff Company to Develop Rare Disease Drugs

Spinoff Company to Develop Rare Disease Drugs

By | January 7, 2015

Maryland-based Vtesse will work with the US National Institutes of Health to advance treatments for Niemann-Pick Type C disease and other lysosomal storage disorders.

1 Comment

image: New Antibiotic from Soil Bacteria

New Antibiotic from Soil Bacteria

By | January 7, 2015

Researchers have isolated a new kind of antibiotic from a previously unknown and uncultured bacterial genus.  

3 Comments

image: 23andMe, Genentech Partner on Parkinson’s

23andMe, Genentech Partner on Parkinson’s

By | January 7, 2015

Firms enter a multi-year deal for the analysis of whole-genome sequence data, with an eye toward drug discovery for Parkinson’s disease.

0 Comments

image: Custom Creatures?

Custom Creatures?

By | January 6, 2015

San Francisco-based biotech wants to see its technology applied for inventing new organisms.

0 Comments

image: Doris Bachtrog: Sex Chromosome Wrangler

Doris Bachtrog: Sex Chromosome Wrangler

By | January 1, 2015

Associate Professor, Department of Integrative Biology, University of California, Berkeley. Age: 39

0 Comments

image: Eye on the Fly

Eye on the Fly

By | January 1, 2015

Automating Drosophila behavior screens gives researchers a break from tedious observation, and enables higher-throughput, more-quantitative experiments than ever before.

0 Comments

image: Funding Research in Africa

Funding Research in Africa

By | January 1, 2015

The ongoing Ebola epidemic in West Africa is drawing more money to study the virus, but what about funding for African science in general?

2 Comments

image: Micro Masterpiece

Micro Masterpiece

By | January 1, 2015

The artful science of Tom Deerinck, a micrographer who consistently places in Nikon’s Small World competition

0 Comments

image: Picturing Infection

Picturing Infection

By | January 1, 2015

Whole-animal, light-based imaging of infected small mammals

4 Comments

image: Rat Race

Rat Race

By | January 1, 2015

Neuroscientist Anthony Zador explains why he uses rats to understand auditory attention in the brain.

0 Comments

Popular Now

  1. Consilience, Episode 3: Cancer, Obscured
  2. RNAi’s Future in Drug-Target Screening
    News Analysis RNAi’s Future in Drug-Target Screening

    A recent CRISPR study contradicted years of RNA interference research on a well-studied cancer drug target. But is it the last nail in the coffin for RNAi as a screening tool? 

  3. A History of Screening for Natural Products to Fight Cancer
  4. Streakers, Poopers, and Performers: The Wilder Side of Wildlife Cameras
AAAS